A prospective study to determine the appropriate number of to-and-fro movements per one pass of EUS-FNB for solid pancreatic lesions
Not Applicable
- Conditions
- solid pancreatic lesions
- Registration Number
- JPRN-UMIN000040285
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients in European Cooperative Oncology Group performance status 4. (2) Patients with severe adverse events in other organs except those involving the original disease (American Society of Anesthesiologists classification greater than 3). (3) Patients contraindicated for cessation of anticoagulant therapy. (4) Pregnant patients or those suspected of being pregnant. (5) Solid pancreatic lesions with definite diagnosis by another biopsy. (6) Solid pancreatic lesions demonstrating difficulty in visualization on EUS. (7) Patients who judged as inappropriate by attendant doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The accuracy of histological diagnosis by the number of to-and-fro movements.
- Secondary Outcome Measures
Name Time Method The total area of the specimen by the number of to-and-fro movements.